Pablo Prieto

Managing Director

8 past transactions

Cercle

Seed Round in 2024
Cercle advances women's healthcare by unlocking access to insights. Cercle’s platform, the Cercle Biomedical Graph™, transforms healthcare data at scale into real-time, high-quality insights that women's healthcare providers use to run more efficient businesses and provide personalized care.

Amelia Virtual Care

Series A in 2022
Amelia Virtual Care is a mental health technology company with offices in Barcelona and Mountain View, specializing in a comprehensive virtual reality platform designed for mental health treatment. This platform enables professionals to address a variety of mental health disorders, including phobias, anxiety, and depression. With a workforce of over 60 employees, Amelia has successfully delivered more than 200,000 VR therapy sessions, primarily in the United States, which serves as its main market. The company's innovative platform includes multiple features and user-friendly controls, facilitating effective therapy sessions. Recent financing and a new management team are expected to enhance Amelia's growth and strengthen its clinical evidence and commercial activities.

Skingdom

Seed Round in 2017
Skingdom is a digital e-health startup focused on personalized skincare solutions. The company offers a range of cosmetic products tailored to individual skin types, supported by a dermatology diagnosis test. Customers receive a customized beauty routine along with tips for effective skincare, ensuring that they can address their specific needs. Skingdom's approach combines product delivery with access to dermatological testing and consultancy, providing a comprehensive platform for wellness coaching in the beauty sector.

Babyscripts

Series A in 2017
Babyscripts is a developer of a virtual maternity care platform aimed at enhancing prenatal and postpartum care for pregnant mothers. The company's three-tiered approach allows healthcare providers to deliver tailored, risk-specific care anytime and anywhere. The first tier features a mobile app that offers daily educational content and resources throughout pregnancy and the postpartum period. The second tier incorporates remote monitoring through medical devices, enabling patients to track health metrics like blood pressure and alerting providers to potential risks. This system facilitates the transition of care beyond traditional clinical settings, enabling providers to focus on higher-risk patients while automating routine care. The third tier fosters collaboration between care teams and insurers, addressing challenges in care coordination and access, ultimately improving health outcomes and reducing costs. Through its innovative platform, Babyscripts aims to eliminate maternal mortality and enhance access to quality care for all mothers.

Virta Health

Series A in 2017
Virta Health Corp. is an online specialty medical clinic dedicated to reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, California, the company utilizes a combination of nutritional biochemistry, clinical expertise, data science, and digital solutions to deliver its innovative treatment. Through its continuous remote care platform, Virta provides extensive medical and behavioral support, which has shown significant results in clinical trials; 60% of enrolled patients achieved diabetes reversal after one year, while 94% of insulin users reduced or eliminated their insulin intake. The benefits of Virta's approach extend beyond diabetes, leading to improvements in blood pressure, inflammation, liver function, and body mass index (BMI), thereby transforming the lives of individuals affected by type 2 diabetes.

S-Biomedic

Seed Round in 2016
S-Biomedic is a biotech company based in Beerse, Belgium, specializing in live probiotic cosmetics aimed at improving skin health. The company develops innovative products that target the skin microbiome, which consists of a diverse community of bacteria that can influence various skin conditions, including acne, eczema, rosacea, and signs of aging. Utilizing advanced modulation-based technology, S-Biomedic selects beneficial bacteria to create formulations that restore balance to the skin's microbiome. This approach not only addresses existing skin issues but also enhances overall skin health and beauty. By bridging advancements in microbiology and dermatology, S-Biomedic offers therapeutic solutions for both dermatological and cosmetic applications.

Genomcore

Seed Round in 2016
Genomcore is a technology company focused on advancing precision healthcare through a robust genome-analysis platform. This platform facilitates the acquisition, analysis, and storage of genomic data, allowing healthcare providers to efficiently manage genetic information without the need for repeated sequencing of the same genome for various tests. In addition to its core genomic services, Genomcore also offers customized applications designed for end-users, enabling the integration of personalized health protocols derived from both biomedical research and primary care. By leveraging artificial intelligence, the company transforms extensive molecular and health data into actionable insights across multiple health domains, including nutrition, emotional well-being, sports, and healthy aging.

Medtep

Seed Round in 2015
Medtep is a digital health company that specializes in personalized medicine, focusing on disease prevention through the monitoring of individuals' lifestyle habits. The company utilizes its platforms, uClinics and uPatient, to aggregate diverse data from various sources such as apps, devices, and sensors, presenting this information in an understandable format for patients with the assistance of healthcare professionals. By enhancing monitoring processes, Medtep enables patients to gain a better understanding of their treatments and fosters a sense of shared responsibility for their health. The company collaborates with a wide range of stakeholders, including pharmaceutical companies, clinical laboratories, medical societies, insurance companies, sports clubs, patient associations, foundations, and research institutions globally, to develop care plans that go beyond clinical protocols and incorporate lifestyle factors into personalized treatment strategies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.